A large proportion of people living with diabetes may have undiagnosed heart failure, according to results from a recent trial. The findings of the TARTAN-HF trial, which were presented at the American College of Cardiology Conference (ACC.26) in New Orleans, suggest that a simple heart-failure screening program for people living with diabetes could dramatically improve diagnosis rates, facilitate the earlier implementation of disease-modifying treatments, and may reduce the risk of hospitalization and death.
This article was originally published on MedicalXpress.com
